Karine Barthélémy

Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity

Suzanne J. F. Kaptein, Sofie Jacobs, Lana Langendries et al. · Proceedings of the National Academy of Sciences · 2020 · 281 citations · Full text

Antiviral Compound, Emerging Infectious Diseases, Lacks Activity +14

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

Jean‐Sélim Driouich, Maxime Cochin, Guillaume Lingas et al. · Nature Communications · 2021 · 146 citations · Full text

Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2

Franck Touret, Jean‐Sélim Driouich, Maxime Cochin et al. · Antiviral Research · 2021 · 48 citations · Full text

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

Jean‐Sélim Driouich, Maxime Cochin, Guillaume Lingas et al. · 2020 · 26 citations · Full text

Medicine, Weight Losses, Plasma Drug Exposure +12

Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2

Jean‐Sélim Driouich, Maxime Cochin, Franck Touret et al. · EBioMedicine · 2022 · 19 citations · Full text